Company intelligence / Profile preview

Herophilus

San Francisco, California, United Statesherophilus.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Herophilus leverages human brain organoids, scaled biology automation, and machine learning to systematically discover novel drugs targeting complex brain diseases. The company has pioneered multi-modal phenotypic screening in vitro to identify new therapeutic targets for disorders like Rett syndrome, Alzheimer’s disease, and schizophrenia. As of late 2023/early 2024 their programs are primarily in preclinical or early validation phases; no published clinical results yet.[1][2][3]

Therapeutic areas
PsychiatryNeurology
Modalities
Small moleculesPotentially others via phenotypic screening and organoid models (not explicitly listed)
Industry
Biotech
02

Drug pipeline

1 asset

Herophilus/Cerevel C4A neuroimmune modulator

Preclinical
03

Partnerships

Genentech/Roche R&D units (strategic transaction involving Herophilus’ discovery platform)[2]

Beyond the preview

Go deeper on Herophilus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herophilus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call